BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/11/2025 8:20:55 AM | Browse: 210 | Download: 589
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 112366
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Involvement of bile acids in cholangiocarcinoma progression via the Hippo-yes-associated protein signaling pathway
Manuscript Source Unsolicited Manuscript
All Author List Jun Hu, Gan Zhang, Shuo Yang, Xian-Feng Shen, Meng Zhou, Lin-Sheng Huang and Hao-Ming Lan
ORCID
Author(s) ORCID Number
Hao-Ming Lan http://orcid.org/0009-0001-4581-6586
Funding Agency and Grant Number
Corresponding Author Hao-Ming Lan, Department of Hepatopancreatobiliary Surgery, Taihe Hospital, Hubei University of Medicine, No. 32 Renmin South Road, Maojian District, Shiyan 442000, Hubei Province, China. bagwell1986@163.com
Key Words Bile acids; Cholangiocarcinoma; Hippo-yes-associated protein signaling; Tumor progression mechanisms; Molecular interventions
Core Tip Cholangiocarcinoma is a highly aggressive malignancy with limited therapeutic options. This study demonstrates that glycochenodeoxycholic acid promotes tumor growth and aggressiveness by activating the Hippo-yes-associated protein (YAP) signaling pathway, whereas deoxycholic acid suppresses tumor progression by enhancing YAP phosphorylation and inducing apoptosis. The use of YAP modulators further confirmed the opposing roles of these bile acids. These findings provide novel mechanistic insights and highlight YAP as a potential therapeutic target, offering new perspectives for bile acid-based intervention strategies in cholangiocarcinoma.
Publish Date 2025-12-11 08:20
Citation

Hu J, Zhang G, Yang S, Shen XF, Zhou M, Huang LS, Lan HM. Involvement of bile acids in cholangiocarcinoma progression via the Hippo-yes-associated protein signaling pathway. World J Gastrointest Oncol 2025; 17(12): 112366

URL https://www.wjgnet.com/1948-5204/full/v17/i12/112366.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i12.112366
Full Article (PDF) WJGO-17-112366-with-cover.pdf